REIMAGINE 3 was a 40-week efficacy and safety phase 3 trial of CagriSema 2.4 mg/2.4 mg and 1 mg/1 mg once-weekly versus placebo in 274 adults with type 2 diabetes as add-on to once-daily basal insulin with or without metformin
Patrice Lindsay 11 , Hardeep Singh 1,5 1 Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada, 2 Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 3 Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada, 4 Section of Geriatric Medicine, Department of Medicine, Sinai Health System and University Health Network, Toronto, Canada, 5 Department of Occupational Science & Occupational Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada, 6 National Institute on Ageing, Toronto Metropolitan University, Toronto, Canada, 7 KITE Research Institute, University Health Network, Toronto, Canada, 8 Department of Physical Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada, 9 North York Toronto Health Partners, North York General Hospital, North York, Canada, 10 Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, Toronto, Canada, 11 MarcLind Health Consulting, Toronto, Canada Background and Aims: In many high-income countries, people of Chinese descent have a higher incidence of certain types of stroke and report experiencing disparities in stroke care due to factors such as language barriers and cultural differences
Toxicol Sci 176:253284
Reconstituted AHK-Cu must be stored at 28C in amber glass vials or opaque containers to prevent light-induced oxidation
Yes survodutide reduced liver fat content by 55% in participants with NASH, measured via MRI-PDFF in Phase 2 trials
